» Articles » PMID: 36247675

Natural Products Targeting Human Lactate Dehydrogenases for Cancer Therapy: A Mini Review

Overview
Journal Front Chem
Specialty Chemistry
Date 2022 Oct 17
PMID 36247675
Authors
Affiliations
Soon will be listed here.
Abstract

Reprogramming cancer metabolism has become the hallmark of cancer progression. As the key enzyme catalyzing the conversion of pyruvate to lactate in aerobic glycolysis of cancer cells, human lactate dehydrogenase (LDH) has been a promising target in the discovery of anticancer agents. Natural products are important sources of new drugs. Up to now, some natural compounds have been reported with the activity to target LDH. To give more information on the development of LDH inhibitors and application of natural products, herein, we reviewed the natural compounds with inhibition of LDH from diverse structures and discussed the future direction of the discovery of natural LDH inhibitors for cancer therapy.

Citing Articles

Altered metabolism in cancer: insights into energy pathways and therapeutic targets.

Tufail M, Jiang C, Li N Mol Cancer. 2024; 23(1):203.

PMID: 39294640 PMC: 11409553. DOI: 10.1186/s12943-024-02119-3.


The elevated lactate dehydrogenase to albumin ratio is a risk factor for developing sepsis-associated acute kidney injury: a single-center retrospective study.

Fang Y, Zhang Y, Zhang X BMC Nephrol. 2024; 25(1):201.

PMID: 38898431 PMC: 11186243. DOI: 10.1186/s12882-024-03636-5.


IGF2BP2 promotes glycolysis and hepatocellular carcinoma stemness by stabilizing CDC45 mRNA via m6A modification.

Liao L, Wu T, Chen S, Yi Q, Xu M Cell Cycle. 2023; 22(20):2245-2263.

PMID: 37985379 PMC: 10730143. DOI: 10.1080/15384101.2023.2283328.


Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases.

Han J, Lee E, Park W, Ha K, Chung H Front Pharmacol. 2023; 14:1275000.

PMID: 37915411 PMC: 10616500. DOI: 10.3389/fphar.2023.1275000.


Synthesis and LDH Inhibitory Activity of Analogues to Natural Products with 2,8-Dioxabicyclo[3.3.1]nonane Scaffold.

Salido S, Alejo-Armijo A, Altarejos J Int J Mol Sci. 2023; 24(12).

PMID: 37373073 PMC: 10298284. DOI: 10.3390/ijms24129925.

References
1.
Schueren F, Lingner T, George R, Hofhuis J, Dickel C, Gartner J . Peroxisomal lactate dehydrogenase is generated by translational readthrough in mammals. Elife. 2014; 3:e03640. PMC: 4359377. DOI: 10.7554/eLife.03640. View

2.
Arora R, Schmitt D, Karanam B, Tan M, Yates C, Dean-Colomb W . Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers. Oncotarget. 2015; 6(2):662-78. PMC: 4359247. DOI: 10.18632/oncotarget.2689. View

3.
Rupiani S, Guidotti L, Manerba M, Di Ianni L, Giacomini E, Falchi F . Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A. Org Biomol Chem. 2016; 14(46):10981-10987. DOI: 10.1039/c6ob01977c. View

4.
Wang J, Wang H, Liu A, Fang C, Hao J, Wang Z . Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer. Oncotarget. 2015; 6(23):19456-68. PMC: 4637298. DOI: 10.18632/oncotarget.3318. View

5.
Lu Q, Zhang L, Yee J, Go V, Lee W . Metabolic Consequences of LDHA inhibition by Epigallocatechin Gallate and Oxamate in MIA PaCa-2 Pancreatic Cancer Cells. Metabolomics. 2015; 11(1):71-80. PMC: 4523095. DOI: 10.1007/s11306-014-0672-8. View